Promethazine
Promethazine, dem sell under de brand name Phenergan among odas, be a first-generation antihistamine, sedative, den antiemetic dem use to treat allergies, nausea, den vomiting. E sanso fi help plus sam symptoms dem associate plus de common cold[1] den sanso fi be used for sedating people wey be agitated anaa anxious, an effect wey lead to sam recreational use (especially plus codeine).[2][3][4] Dem dey take promethazine by mouth (oral), as a rectal suppository, anaa by injection into a muscle (IM).[1]
| Subclass of | phenothiazine, Medication |
|---|---|
| Native label | Promethazine |
| Chemical formula | C₁₇H₂₀N₂S |
| Canonical SMILES | CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C |
| Active ingredient in | Phenergan, Phenadoz, Promethegan |
| World Health Organisation international non-proprietary name | promethazine |
| Medical condition treated | vomiting, motion sickness, postoperative complications, pain |
| Physically dey interact plus | Histamine receptor H1 |
| Pregnancy category | Australian pregnancy category C, US pregnancy category C |
| LiverTox likelihood score | LiverTox toxicity likelihood category E |
| Subject has role | antipruritic, dopamine antagonist, H1 antagonist, anti-allergic agents |
| MCN code | 2934.30.30 |
Common side effects of promethazine dey include confusion den sleepiness;[1] consumption of alcohol anaa oda sedatives fi make dese symptoms worse.[1] E be unclear if use of promethazine during pregnancy anaa breastfeeding be safe.[1][5] Use of promethazine no be recommended insyd those less dan two years old, secof potentially negative effects on breathing.[1] Use of promethazine by injection into a vein no be recommended, secof potential skin damage.[1] Promethazine dey insyd de phenothiazine family of medications.[1] E sanso be a strong anticholinergic den at high anaa toxic doses fi act as a deliriant.[6]
Dem make promethazine insyd de 1940s by a team of scientists wey komot Rhône-Poulenc laboratories.[7] Na e be approved for medical use insyd de United States insyd 1951.[1] E be a generic medication wey be available under chaw brand names globally.[8] Insyd 2023, na e be de 230th most commonly prescribed medication insyd de United States, plus more dan 1 million prescriptions;[9][10] den de combination plus dextromethorphan be de 252nd most commonly prescribed medication insyd de United States, plus more dan 1 million prescriptions.[11][12]
Pharmacology
editAnoda notable use of promethazine be as a local anesthetic, by blockage of sodium channels.[13]
| receptor | Ki (nM) | ref |
|---|---|---|
| α1A-adrenoceptor (Rat) | 32 | [14] |
| α1B-adrenoceptor (Rat) | 21 | [14] |
| α1D-adrenoceptor (Human) | 90 | [14] |
| α2A-adrenoceptor (Human) | 256 | [14] |
| α2B-adrenoceptor (Human) | 24 | [14] |
| α2C-adrenoceptor (Human) | 353 | [14] |
| Calmodulin (Human) | 60000 | [15][14][16] |
| Calmodulin (Bovine) | 50000 | [15][16][14] |
| Chloroquine resistance transporter (Plasmodium falciparum) | 85000 | [17][14] |
| D1 receptor (Human) | 1372 | [14] |
| D2 receptor (Human) | 260 | [14] |
| D3 receptor (Human) | 190 | [14] |
| H1 receptor (Human) | 0.33[14]-1.4[18] | [18][14] |
| H2 receptor (Human) | 1146 | [14] |
| M1 receptor (Human) | 3.32 | [14] |
| M2 receptor (Human) | 12 | [14] |
| M3 receptor (Human) | 4.15 | [14] |
| M4 receptor (Human) | 1.06 | [14] |
| M5 receptor (Human) | 3.31 | [14] |
| NET (Norephinephrine transporter) (Human) | 4203 | [14] |
| Prion protein (Human) | 8000 | [19][14] |
| 5-HT1A receptor (Rat) | 1484 | [14] |
| 5-HT2A receptor (Human) | 19 | [14] |
| 5-HT2B receptor (Human) | 43 | [14] |
| 5-HT2C receptor (Human) | 6.48 | [14] |
| 5-HT6 receptor (Human) | 1128 | [14] |
| SERT (Serotonin transporter) (Human) | 2130 | [14] |
| Sigma1 receptor (Human) | 120 | [14] |
| OCT1 (Human) | 35100 | [20][14] |
References
edit- 1 2 3 4 5 6 7 8 9 "Promethazine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 24 October 2018.
- ↑ Agnich LE, Stogner JM, Miller BL, Marcum CD (September 2013). "Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures" (PDF). Addictive Behaviors. 38 (9): 2445–9. doi:10.1016/j.addbeh.2013.03.020. PMID 23688907.
- ↑ British national formulary: BNF 74 (74 ed.). British Medical Association. 2017. p. 276. ISBN 978-0-85711-298-9.
- ↑ Malamed SF (2009). Sedation: A Guide to Patient Management (in English). Elsevier Health Sciences. p. 113. ISBN 978-0-323-07596-1.
- ↑ British national formulary: BNF 74 (74 ed.). British Medical Association. 2017. p. 276. ISBN 978-0-85711-298-9.
- ↑ Page CB, Duffull SB, Whyte IM, Isbister GK (February 2009). "Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal". QJM. 102 (2): 123–131. doi:10.1093/qjmed/hcn153. PMID 19042969. S2CID 17677540.
- ↑ Li JJ (2006). Laughing Gas, Viagra, and Lipitor: The Human Stories behind the Drugs We Use. United Kingdom: Oxford University Press. p. 146. ISBN 978-0-19-988528-2. Retrieved 9 July 2016.
- ↑ "Promethazine international brands". Drugs.com. Retrieved 17 July 2017.
- ↑ "The Top 300 of 2023". ClinCalc. Archived from the original on 17 August 2025. Retrieved 17 August 2025.
- ↑ "Promethazine Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 17 August 2025.
- ↑ "The Top 300 of 2023". ClinCalc. Archived from the original on 17 August 2025. Retrieved 17 August 2025.
- ↑ "Dextromethorphan; Promethazine Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 17 August 2025.
- ↑ Prasad JP (2010). Conceptual Pharmacology. Universities Press. pp. 295, 303, 598. ISBN 978-81-7371-679-9. Retrieved 27 November 2011.
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 "promethazine | Ligand Activity Charts | IUPHAR/BPS Guide to PHARMACOLOGY". www.guidetopharmacology.org (in English). Retrieved 18 May 2023.
- 1 2 Bruno C, Cavalluzzi MM, Rusciano MR, Lovece A, Carrieri A, Pracella R, Giannuzzi G, Polimeno L, Viale M, Illario M, Franchini C, Lentini G (June 2016). "The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca(2+)/calmodulin-dependent kinase II". European Journal of Medicinal Chemistry. 116: 36–45. doi:10.1016/j.ejmech.2016.03.045. PMID 27043269.
- 1 2 Bolshan Y, Getlik M, Kuznetsova E, Wasney GA, Hajian T, Poda G, Nguyen KT, Wu H, Dombrovski L, Dong A, Senisterra G, Schapira M, Arrowsmith CH, Brown PJ, Al-Awar R, Vedadi M, Smil D (March 2013). "Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction". ACS Medicinal Chemistry Letters. 4 (3): 353–357. doi:10.1021/ml300467n. PMC 4027439. PMID 24900672.
- ↑ Deane KJ, Summers RL, Lehane AM, Martin RE, Barrow RA (May 2014). "Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT". ACS Medicinal Chemistry Letters. 5 (5): 576–581. doi:10.1021/ml5000228. PMC 4027738. PMID 24900883.
- 1 2 Nakai T, Kitamura N, Hashimoto T, Kajimoto Y, Nishino N, Mita T, Tanaka C (August 1991). "Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia". Biological Psychiatry. 30 (4): 349–356. doi:10.1016/0006-3223(91)90290-3. PMID 1912125. S2CID 9715772.
- ↑ Vogtherr M, Grimme S, Elshorst B, Jacobs DM, Fiebig K, Griesinger C, Zahn R (August 2003). "Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein". Journal of Medicinal Chemistry. 46 (17): 3563–3564. doi:10.1021/jm034093h. PMID 12904059.
- ↑ Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P (October 2008). "Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1". Journal of Medicinal Chemistry. 51 (19): 5932–5942. doi:10.1021/jm8003152. PMID 18788725.